Data-Driven Decision Making

The creator economy has mastered ROI-driven engagement. Can healthcare use its AI-powered playbook to improve patient outcomes and combat misinformation?

As AI-native fintech Henon plants its flag in London, its push for 'zero-error' finance signals a new competitive era for private capital in EMEA.

A California fragrance brand conquered Korea and now targets the U.S. We dissect the data-driven strategy and AI's quiet role in its rapid rise.

PathAI's AIM-MASH tool just got dual FDA/EMA approval, a first for AI pathology. This could slash MASH drug development time and reshape clinical trials.

A $2.4B tech acquisition seems distant from healthcare, but Qualcomm's move to buy Alphawave is building the essential AI infrastructure for medicine's future.

Allbirds co-founder Joey Zwillinger is applying consumer tech disruption to women's health. Can Biologica's science-backed model reshape a stagnant market?

A new $500M USACE contract shows how Tetra Tech is turning advanced AI and data analytics into profitable solutions for America's toxic waste problems.

Facing federal overhaul and public outcry, top organizations pledge reform. Can innovation and transparency fix a broken system and save thousands of lives?

Angeion Group's appointment of a legal marketing veteran isn't just a new hire; it's a calculated move to challenge rivals and dominate its niche.

LRN appoints Bob Lemmond as CEO, a strategic move signaling a deeper push into data-driven ethics amid rising AI regulations and market complexity.

A new partnership aims to turn dusty tape libraries into revenue streams using AI, marking a major strategic shift for a legacy hardware maker.

A.D.A.M. Innovations just launched ALUNAÉ, the world's first AI genomic-based skincare. Is this the future of beauty or a step too far?

Groundbreaking lymphoma data and a strategic acquisition position Natera to dominate the liquid biopsy market, challenging old standards and creating new value.

Beyond the press release: How two strategic hires signal Plus Therapeutics' aggressive push to commercialize its CNSide platform and capture a $6B market.

A new lab system combines speed, multiplexing, and regulatory trust, promising to accelerate drug development and deepen our biological understanding.

Paychex is betting on AI to transform HR, from automating payroll to mining unstructured data. Is this the future of workforce management?

Beyond insurance, Sammons Financial Group is building a holistic financial services model. What does this strategic pivot mean for clients and the industry?

A new partnership aims to advance a novel antibody for FTLD, a devastating dementia, showcasing a powerful model for biotech innovation and strategic growth.

A routine filing from wealth manager Rathbones reveals its 7.01% stake in Idox Plc, putting a spotlight on the software firm's acquisition and its future.

Antero Resources executes a complex asset swap, doubling down on the Marcellus Shale. We break down the financial engineering behind the multi-billion dollar deal.